FDA Offers Pharmacists Opioid Training

Posted on September 27, 2018 by Pharmaciststeve

FDA Offers Pharmacists Opioid Training http://www.drugtopics.com/fda/fda-offers-pharmacists-opioid-training The FDA’s new opioids Risk Evaluation and Mitigation Strategy (REMS) plan offers training to pharmacists and nurses for the first time, and adds new labeling for all opioids. The agency’s final Opioid Analgesic REMS includes several measures to help better communicate the serious risks about the use of opioid painkillers […]

Filed under: General Problems | 4 Comments »

DEA reschedules Epidiolex, marijuana-derived drug, paving the way for it to hit the market

Posted on September 27, 2018 by Pharmaciststeve

DEA reschedules Epidiolex, marijuana-derived drug, paving the way for it to hit the market The Food and Drug Administration in June approved Epidiolex, which is derived from cannabidiol, or CBD, a molecule contained in the marijuana plant. This forced the DEA to consider how it would classify Epidiolex since marijuana is considered a schedule 1 […]

Filed under: General Problems | 1 Comment »

CIAAG Calls for Pain management as Human Right to the United Nations

Posted on September 27, 2018 by Pharmaciststeve

Lauren Deluca, founding president of Chronic Illness Advocacy & Awareness Group (CIAAG), addressed the United Nations’ Commission on Narcotic Drugs today on the effects of the United States’ opioid crisis policies on chronic pain patients. CIAAG also proposed practical solutions to help monitor opioid use and ensure patients access to essential healthcare. Ms. Deluca warned, […]

Filed under: General Problems | 6 Comments »